The estimated Net Worth of Dave Hoffmann is at least $164 Thousand dollars as of 21 September 2017. Dave Hoffmann owns over 95,000 units of Molecular Templates Inc stock worth over $164,400 and over the last 20 years Dave sold MTEM stock worth over $0.
Dave has made over 3 trades of the Molecular Templates Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Dave exercised 95,000 units of MTEM stock worth $98,800 on 21 September 2017.
The largest trade Dave's ever made was buying 200,000 units of Molecular Templates Inc stock on 26 April 2016 worth over $250,000. On average, Dave trades about 9,143 units every 56 days since 2004. As of 21 September 2017 Dave still owns at least 120,000 units of Molecular Templates Inc stock.
You can see the complete history of Dave Hoffmann stock trades at the bottom of the page.
Dave's mailing address filed with the SEC is C/O MOLECULAR TEMPLATES, INC., 9301 AMBERGLEN BLVD., SUITE 100, AUSTIN, TX, 78729.
Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch, and Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.
Molecular Templates Inc executives and other stock owners filed with the SEC include: